Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Gingival Diseases: early-phase trial registry

2 of 5 indexed Gingival Diseases trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Gingival Diseases: 5 US clinical trials tracked, 2 recruiting.

Gingival Diseases is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Biomedical Development Corporation, running 1 of these trials.

Enrollment posture brief

Registry condition gingival-diseases

OPEN 2 | RECR 40% | LATE 0 | EARLY 1 | RANK #3391 | SPON 1

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Gingival Diseases (this)40%
Open-enrollment share among volume-matched conditions near Gingival Diseases

Gingival Diseases lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Gingival Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Gingival Diseases is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Gingival Diseases research.

    Biomedical Development Corporation accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Gingival Diseases trials plan to enrol fewer than 100 people.

    Median target enrolment is 76 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.

  4. Gingival Diseases research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Gingival Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Sutures Procedure
1 trials
amnion-chorion membrane Device
1 trials
Frio Oral Rinse Drug
1 trials
0.454% Stannous Fluoride Dentifrice Drug
1 trials
0.76% Sodium Monofluorophosphate Dentifrice Drug
1 trials
Optical imaging of the tissues Device
1 trials
SRP + standard flouride dentifrice Other
1 trials
SRP + Livfresh Dental Gel Other
1 trials

US sites by state

Facility locations filed on Gingival Diseases trials. A trial with sites in several states counts in each.

Massachusetts 2 trials
Nevada 1 trials
Missouri 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Gingival Diseases page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gingival Diseases condition card totals 5 registered trials; most-linked intervention Sutures; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.